Anthony Jaworski, PharmD, BCCCP, DABAT
Areas of expertise: Toxicology, Critical Care
About Anthony Jaworski
Dr. Jaworski coordinates clinical activities for the Poison Control Center to ensure optimal poison information and toxicology support to the community's patients and providers. He also serves as the Poison Control’s liaison to the Pharmacy Department and Medication Safety Officer.
Titles
Clinical Program Manager, Poison Control Center
Certifications
Diplomate of the American Board of Applied Toxicology (DABAT)
Leadership and Memberships
Memberships in Professional Organizations
American Academy of Clinical Toxicology (AACT)
American Association of Poison Control Centers (AAPCC)
American Society of Health-System Pharmacists (ASHP)
Research Interests
Public health Substance-use disorders Toxicology
Education & training
Graduate Degree
Doctor of Pharmacy - Wayne State University, Detroit, MI
Residency
Pharmacy Residency (PGY-1) - Henry Ford Hospital, Detroit, MI
Critical Care Specialty (PGY-2) - West Virginia University Medicine, Morgantown, WV
Publications
Publications
2020
Hurth KP, Jaworski A, Thomas KB, Kirsch WB, Rudoni MA, Wohlfarth KM. “The re-emergence of ketamine for treatment in critically-ill adults.” Critical Care Medicine. 2020;48(6):899-911.
2017
Zygowiec J, Solomon S, Jaworski A, Gotlib A, Bloome M. “25C NBOMe ingestion.” Clinical Practice and Cases in Emergency Medicine. 2017;1(4):295-7.
2013
Carreno JJ, Jaworski A, Kenney RM, Davis SL. “Comparative incidence of nephrotoxicity by age group among adult patients receiving vancomycin.” Infectious Diseases and Therapy. 2013;2:201-8.